Joseph A Trapani Selected Research

Joseph A Trapani Research Topics

Disease

54	Neoplasms (Cancer) 04/2022 - 03/2002
5	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 02/2012 - 09/2004
4	Infections 01/2020 - 02/2007
4	Virus Diseases (Viral Diseases) 01/2019 - 04/2010
4	Leukemia 05/2017 - 03/2003
3	Hematologic Neoplasms (Hematological Malignancy) 01/2019 - 12/2013
3	Graft vs Host Disease (Graft-Versus-Host Disease) 09/2017 - 02/2015
3	Lymphoma (Lymphomas) 12/2008 - 07/2002
2	Multiple Myeloma 06/2022 - 02/2011
2	Melanoma (Melanoma, Malignant) 01/2022 - 01/2021
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2021 - 11/2013
2	Sarcoma (Soft Tissue Sarcoma) 11/2021 - 09/2021
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 12/2017 - 01/2012
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 03/2017 - 07/2014
2	Breast Neoplasms (Breast Cancer) 01/2017 - 08/2004
2	Inflammation (Inflammations) 08/2010 - 05/2010
2	Carcinoma (Carcinomatosis) 04/2009 - 11/2002
2	Neoplasm Metastasis (Metastasis) 11/2005 - 11/2002
1	Colitis 01/2022
1	Type C Niemann-Pick Disease (Niemann Pick Disease, Type C) 01/2022
1	COVID-19 12/2021
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2020
1	Brain Neoplasms (Brain Tumor) 01/2020
1	Acute Liver Failure (Fulminant Hepatic Failure) 01/2020
1	Stomach Neoplasms (Stomach Cancer) 01/2018
1	Metaplasia 01/2018
1	Gastritis 01/2018
1	Autoimmune Diseases (Autoimmune Disease) 12/2017
1	Triple Negative Breast Neoplasms 01/2017
1	Cytokine Release Syndrome 09/2015

Drug/Important Bio-Agent (IBA)

22	PerforinIBA 01/2019 - 03/2002
17	Granzymes (Granzyme)IBA 01/2021 - 03/2002
12	AntigensIBA 01/2020 - 11/2002
11	Chimeric Antigen ReceptorsIBA 09/2021 - 11/2013
11	Proteins (Proteins, Gene)FDA Link 10/2020 - 09/2004
10	CytokinesIBA 01/2022 - 07/2002
6	Immune Checkpoint InhibitorsIBA 04/2022 - 01/2020
5	AutoantigensIBA 05/2017 - 11/2002
4	RNA (Ribonucleic Acid)IBA 01/2022 - 10/2020
3	EnzymesIBA 01/2022 - 04/2009
3	Peptides (Polypeptides)IBA 01/2021 - 11/2002
3	Messenger RNA (mRNA)IBA 10/2020 - 01/2014
3	LigandsIBA 01/2017 - 11/2002
2	Lenalidomide (CC 5013)FDA Link 06/2022 - 02/2011
2	InterleukinsIBA 01/2022 - 07/2002
2	Serine Proteases (Serine Protease)IBA 01/2020 - 10/2003
2	Neoplasm Antigens (Tumor Antigens)IBA 01/2020 - 03/2012
2	Transforming Growth Factor beta (TGF-beta)IBA 01/2020 - 11/2005
2	EpitopesIBA 01/2020 - 05/2017
2	VaccinesIBA 01/2020 - 05/2017
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2020 - 12/2015
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018 - 07/2002
2	InterferonsIBA 01/2018 - 07/2002
2	Interleukin-2 (IL2)IBA 05/2017 - 12/2007
2	Histone Deacetylase InhibitorsIBA 01/2017 - 08/2003
2	Trastuzumab (Herceptin)FDA Link 01/2017 - 08/2004
2	Cathepsin CIBA 05/2011 - 02/2007
2	CarbohydratesIBA 04/2009 - 12/2005
2	chenodeoxycholate sulfate conjugate (CDCS)IBA 09/2008 - 09/2007
2	CaspasesIBA 10/2003 - 03/2003
2	Single-Chain AntibodiesIBA 11/2002 - 11/2002
2	Interferon-gamma (Interferon, gamma)IBA 11/2002 - 07/2002
1	elotuzumabIBA 06/2022
1	Carrier Proteins (Binding Protein)IBA 01/2022
1	Food Coloring AgentsIBA 01/2022
1	Interleukin-23 (Interleukin 23)IBA 01/2022
1	ChromatinIBA 01/2022
1	CholesterolIBA 01/2022
1	Bispecific AntibodiesIBA 01/2022
1	Antiviral Agents (Antivirals)IBA 12/2021
1	poliovirus receptorIBA 12/2021
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 11/2021
1	Polysaccharides (Glycans)IBA 01/2021
1	SugarsIBA 01/2021
1	Death Domain ReceptorsIBA 10/2020
1	Copper Transporter 1IBA 10/2020
1	B7-H1 AntigenIBA 10/2020
1	Blocking AntibodiesIBA 10/2020
1	Chelating AgentsIBA 10/2020
1	CopperIBA 10/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	ibrutinibIBA 01/2020
1	Cancer VaccinesIBA 01/2020
1	zanubrutinibIBA 01/2020
1	Cysteamine (Mercaptamine)FDA Link 01/2018
1	beta-apocarotenoid-14',13'-dioxygenase (ADO)IBA 01/2018
1	DioxygenasesIBA 01/2018
1	NucleotidesIBA 12/2017
1	Interferon Type IIBA 12/2017
1	Chemokine ReceptorsIBA 05/2017
1	Adenosine (Adenocard)FDA LinkGeneric 03/2017
1	AntibodiesIBA 01/2017
1	PanobinostatIBA 01/2017
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2017
1	Cytostatic AgentsIBA 01/2017

Therapy/Procedure

22	Therapeutics 01/2022 - 08/2004
21	Immunotherapy 04/2022 - 11/2002
3	Drug Therapy (Chemotherapy) 11/2021 - 08/2003
3	Ligation 05/2015 - 11/2005
2	Radiotherapy 11/2021 - 01/2017